Jinglu Jin

发表

Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes

R. Santos, Cheng-gang Zhu, Xiao-lin Li, 2020, Cardiovascular Diabetology.

Lipoprotein(a) Is Associated with the Presence and Severity of New-Onset Coronary Artery Disease in Postmenopausal Women.

Cheng-gang Zhu, Li-feng Hong, Yuan-Lin Guo, 2020, Journal of women's health.

Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease: A Matched Case–Control Study

Cheng-gang Zhu, Yuan-Lin Guo, N. Wu, 2019, Clinical and translational gastroenterology.

Association of invasive treatment and lower mortality of patients ≥ 80 years with acute myocardial infarction: a propensity-matched analysis

N. Wu, Jian‐Jun Li, Jinglu Jin, 2018, Journal of geriatric cardiology : JGC.

The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia.

Cheng-gang Zhu, Yuan-Lin Guo, N. Wu, 2018, Atherosclerosis.

Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis

Cheng-gang Zhu, Yuan-Lin Guo, N. Wu, 2021, Cardiovascular Diabetology.

Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Journal of translational medicine.

Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Journal of translational medicine.

Lipoprotein (a), hypertension, and cardiovascular outcomes: a prospective study of patients with stable coronary artery disease

Cheng-gang Zhu, Yuan-Lin Guo, N. Wu, 2021, Hypertension Research.

Lipoprotein(a) as a marker for predicting coronary collateral circulation in patients with acute myocardial infarction.

Cheng-gang Zhu, Yuan-Lin Guo, N. Wu, 2019, Personalized medicine.

Differential leukocyte counts and cardiovascular mortality in very old patients with acute myocardial infarction: a Chinese cohort study

Cheng-gang Zhu, Li-feng Hong, Yuan-Lin Guo, 2020, BMC Cardiovascular Disorders.

Baseline and on-statin treatment lipoprotein(a) levels for predicting cardiovascular events in patients with familial hypercholesterolemia.

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Atherosclerosis.

A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH)

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Molecular Diagnosis & Therapy.

Lipoprotein(a) and cardiovascular death in oldest-old (≥80 years) patients with acute myocardial infarction: A prospective cohort study.

Jian‐Jun Li, Huihui Liu, Jinglu Jin, 2020, Atherosclerosis.

Plasma proprotein convertase subtilisin/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia.

R. Santos, Yuan-Lin Guo, N. Wu, 2019, European journal of preventive cardiology.

Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy

Jian Li, Yuan-Lin Guo, N. Wu, 2019, Journal of Translational Medicine.

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2022, Frontiers in Cardiovascular Medicine.

Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease

R. Santos, Yuan-Lin Guo, N. Wu, 2020, Journal of Lipid Research.

Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease.

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Journal of thoracic disease.

Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Journal of Translational Medicine.

Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Journal of Translational Medicine.

NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2022, Lipids in health and disease.

Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study

Xiao-lin Li, Yuan-Lin Guo, N. Wu, 2020, Cardiovascular Diabetology.

Apoprotein C-III: A review of its clinical implications.

Yuan-Lin Guo, Jian‐Jun Li, Jinglu Jin, 2016, Clinica chimica acta; international journal of clinical chemistry.

Liver Fibrosis Scoring Systems as Novel Tools for Predicting Recurrent Cardiovascular Events in Patients with a Prior Cardiovascular Event

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2021, Cardiology Discovery.

Heart-type fatty acid binding protein predicts cardiovascular events in patients with stable coronary artery disease: a prospective cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Annals of translational medicine.

Improvement of oxidative stress status by lipoprotein apheresis in Chinese patients with familial hypercholesterolemia

Xiao-lin Li, Yuan-Lin Guo, Jian‐Jun Li, 2019, Journal of clinical laboratory analysis.

Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study

M. Zheng, Yuan-Lin Guo, N. Wu, 2021, Hepatology International.

Lipoprotein(a) and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: A Prospective Cohort Study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Thrombosis and Haemostasis.

Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Cardiovascular Diabetology.

Lipoprotein(a) as a predictor for the presence and severity of premature coronary artery disease: a cross-sectional analysis of 2433 patients

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Coronary artery disease.

Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Annals of medicine.

Impact of liver fibrosis score on prognosis in patients with previous myocardial infarction: A prospective cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Clinical impact of blood pressure on cardiovascular death in patients 80 years and older following acute myocardial infarction: a prospective cohort study

Jian Li, Li-feng Hong, Jinglu Jin, 2022, Hypertension Research.

Plasma free fatty acids in relation with the severity of coronary artery disease in non-diabetics: A Gensini score assessment

Yuan-Lin Guo, Jian‐Jun Li, Jinglu Jin, 2017 .

Intensive genetic analysis for Chinese patients with very high triglyceride levels: Relations of mutations to triglyceride levels and acute pancreatitis

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, EBioMedicine.

The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes

Xiao-lin Li, Yuan-Lin Guo, N. Wu, 2020, Cardiovascular Diabetology.

Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease

Li-feng Hong, Yuan-Lin Guo, N. Wu, 2020, Heart.

Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long‐Term Follow‐up Study on Real‐World Patients Receiving Percutaneous Coronary Intervention

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Journal of the American Heart Association.

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Diabetes Care.

Improvement of Definite Diagnosis of Familial Hypercholesterolemia Using an Expanding Genetic Analysis

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2021, JACC. Asia.

Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2021, Cardiovascular Diabetology.

Association of small dense LDL-cholesterol with disease severity, hypertension status and clinical outcome in patients with coronary artery disease

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Journal of hypertension.

Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Cardiovascular Diabetology.

Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2018, Journal of Translational Medicine.

The value of HDL subfractions in predicting cardiovascular outcomes in untreated, diabetic patients with stable coronary artery disease: An age- and gender-matched case-control study

K. Dou, Yuan-Lin Guo, Jian‐Jun Li, 2023, Frontiers in Endocrinology.

Atherogenic dyslipidaemia and cardiovascular events in patients with diabetes or pre-diabetes and stable coronary artery disease: a prospective, cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2021, BMJ Open.

Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2021, Hepatology International.

Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Cardiovascular Diabetology.

Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Journal of Translational Medicine.

High-sensitivity C-reactive protein and hypertension: combined effects on coronary severity and cardiovascular outcomes

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Hypertension Research.

Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2020, Cardiovascular Diabetology.

Visit-to-visit variability of lipid and cardiovascular events in patients with familial hypercholesterolemia

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2021, Annals of translational medicine.

Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2021, Journal of the American Heart Association.

A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH)

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Molecular Diagnosis & Therapy.

Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Journal of Translational Medicine.

Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study

Jian Li, Yuan-Lin Guo, N. Wu, 2021, Hepatology International.

High-sensitivity C-reactive protein and hypertension: combined effects on coronary severity and cardiovascular outcomes

Yuan-Lin Guo, N. Wu, Jian‐Jun Li, 2019, Hypertension Research.